KG LEGAL \ INFO
BLOG

KIELTYKA GLADKOWSKI TAKES PART IN INTERNATIONAL FOODTECH EXPO FOOD TECHNOLOGY FAIR – 23-25 NOVEMBER 2021

Considering global food and agricultural problems KIEŁTYKA GŁADKOWSKI KG LEGAL PROFESSIONAL PARTNERSHIP. ATTORNEY LAW FIRM will take part in the FoodTech Expo, International Food Technology Fair (2nd edition) on 23-25 November 2021 in Warsaw.

The Food Technology Fair is a presentation of a comprehensive offer of producers and distributors of machines for food processing and production, technologies increasing food safety, and presentation of additives and components for food and novel food.

The participants of the Foodtech Fair will include, among others, the representatives of the main players in the foodtech market, like the companies of specialist machines and technological liners for the food industry sector; machines and supporting devices, accessories; food production components and additives; services, research and science.

FoodTech and AgTech law sectors remain within the specialization of KIELTYKA GLADKOWSKI law firm, with emphasis on Agricultural robotics, crop science, plant based eco-friendly meat and regulatory aspects of the latter, machine learning and technology in agtech and foodtech.

Home

More

KIELTYKA GLADKOWSKI TAKES PART IN A WEBINAR DEVOTED TO CRYPTOCURRENCY VALUATION ISSUES AND MARKET VOLATILITY

On September 1, 2021, as members of American Bankruptcy Institute KIELTYKA GLADKOWSKI will take part in the webinar Cryptocurrency: Valuation issues and market volatility, sponsored by the Financial Advisors and Investment Banking Committee.

The American Bankruptcy Institute is the US largest and most diverse community of bankruptcy professionals. ABI provides essential resources for insolvency professionals including:

  • Opinions
  • Consumer commission
  • Blog exchange
  • ABI Law Review
  • Daily news headlines on insolvency developments around the globe
  • ABI Journal

During the webinar three cryptocurrency industry experts – a lawyer, a technical consultant and an investment banker will cover the complexity of valuing cryptocurrency and provide their expert views on the crypto-market volatility, both currently and going forward. The presenters will also offer their insights into the adoption of cryptocurrency in the U.S. and globally, and will address regulatory changes in banking as they relate to cryptocurrencies.

More

KIEŁTYKA GŁADKOWSKI KG LEGAL TOOK PART IN CELL AND GENE DATA INNOVATION AND MULTI-STAKEHOLDER DATA TRANSFER WEBINAR

On 29 July 2021 KIEŁTYKA GŁADKOWSKI KG LEGAL took part in the webinar ‘Cell and gene data innovation and multi-stakeholder data transfer’ (Plan, capture and set the infrastructure for data sharing across the value chain, to optimize commercial strategy), organized by Reuters Events in participation and partnership with Salesforce. The scope of the webinar is within life science and digital health specialization that constitutes one of the core specializations of our law firm.

Some of the panelists included:

Augusto Penjasoff – Business Partner, Global Cell Therapy IT Head in BMS (Bristol Myers Squibb),

Curt Fitzgerald – Director- Service Delivery- C&GT in Novartis,

Gary Gabriel – Global Advisor for Healthcare and Life Sciences in Tableau,

Neary Detrick – Senior Director, Data Management & Analytics in Bluebird Bio,

and Beth Hayes as a moderator- healthcare and lifesciences business consulting – Pharma Lead, Industry Transformation (Salesforce).

The mission of Salesforce company (a partner and a participant of the webinar) is to empower companies to connect with the customers, providers of services and patients in the new and reimagined way. Salesforce serves leading organizations across the industry, including pioneers in CGT (cell and gene therapy).

Important question posed during the webinar concerned personalized medicine.

The response is that the latter is the future of the medicine (so-called a Medicine 2.0). A deliberation about personalized medicine is not a discussion about future in about 10 or 15 years. It drives a magnificent impact across the industry. There was also discussed the question of the difference between the traditional medicine and personalized medicine.

More

KIELTYKA GLADKOWSKI TAKES PART IN WEBINAR- CELL AND GENE DATA INNOVATION AND MULTI-STAKEHOLDER DATA TRANSFER

PLAN, CAPTURE AND SET THE INFRASTRUCTURE FOR DATA SHARING ACROSS THE VALUE CHAIN, TO OPTIMIZE COMMERCIAL STRATEGY.

On July 29, 2021 KG Legal Kiełtyka Gładkowski will take part in webinar ‘Cell and gene data innovation and multi-stakeholder data transfer’ organized by Reuters as part of the activities of Pharma Boardroom (the global platform for C -level healthcare executives) in partnership with Sales force. This online-conference will focus on the life-changing cell and gene therapies and related with it value chains of these therapies and data transfer between the stakeholders.

More

THE ANNUAL GENERAL MEETING OF THE BIOLAW EUROPE ASSOCIATION

Berlin – the seat of Dierks + Company – the place of the next
8th AGM of BioLawEurope FmbA

The 7th Annual General Meeting of the Danish-based international legal organization BioLaw Europe FmbA ended on June 30, 2021. This year the organization held online AGM meeting. During the AGM a new board was elected.

THE 2021/22 BOARD OF DIRECTORS, MANAGEMENT & AUDITOR is composed of:

Mark Anderson, Attorney-at-Law, Chairman & Director.

Christian Dierks, Attorney-at-Law, Vice Chairman & Director.

Sonja Hebenstreit, Attorney-at-Law, Director.

Linda Longo, Attorney-at-Law, Director.

Olivier van Obberghen, Attorney-at-Law, Director.

Jan Bjerrum Bach, Attorney-at-Law, Secretary & Treasurer.

K. Jakub Gładkowski, Attorney-at-Law, Auditor.

BIOLAW EUROPE is a legal organization associating law firms specializing, inter alia, in providing legal services to business entities from the life sciences and pharmaceutical market, including regulatory law in the European Union, for example regarding the legal situation of the most modern medicinal products today, such as advanced therapy medical devices and genetic material engineering.

Full information about BIOLAW EUROPE can be found at:

https://www.jusmedico.com/biolaweurope-f-m-b-a/

More

UP